כרומו קומוד תרסיס לאף
kivema ltd - cromoglicic acid as sodium - ספריי לאף - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid - cromoglicic acid - prophylactic treatment for allergic rhinitis, seasonal and perrenial.
קרומופטיק
vitamed pharmaceutical industries ltd - cromoglicic acid sodium - טיפות עיניים - cromoglicic acid sodium 2 %w/v - cromoglicic acid - cromoglicic acid - preventative treatment of all forms of allergic conjunctivitis.
קרונאז תרסיס לאף
vitamed ltd,binyamina - cromoglicic acid sodium 20 mg/ml - solution - cromoglicic acid - cronase is indicated for the prevention and treatment of seasonal and non seasonal allergic rhinitis.
כרומו קומוד טיפות עיניים
kivema ltd - cromoglicic acid as sodium - טיפות עיניים - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid
אופטיקרום טפות עיניים
sanofi - aventis israel ltd - cromoglicic acid as sodium 2 %w/v - eye drops - cromoglicic acid - preventive treatment for all types of allergic conjunctivitis.
וילאט 1000
dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii
וילאט 500
dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii
פלוטיפורם 505
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.
פלוטיפורם 1255
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.
פלוטיפורם 25010
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.